Paper41312367
Advances in interleukin-10-based therapies for pulmonary diseases: focus on targeted lung delivery systems.
Tian W and 7 others. Front Immunol, 2025. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Advances in interleukin-10-based therapies for pulmonary diseases: focus on targeted lung delivery systems. Papers, record 41312367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41312367
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Advances in interleukin-10-based therapies for pulmonary diseases: focus on targeted lung delivery systems.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interleukin-10 | Major topic |
| Drug Delivery Systems | Major topic |
| Lung Diseases | Major topic |
| Lung | Major topic |
| Humans | |
| Animals |
Source PubMed
References160
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19408293 | Absorption of polyethylene glycol (PEG) polymers: the effect of PEG size on permeability. | J Pharm Sci | 2009 | https://conductscience.org/library/papers/19408293 | PubMed |
| 2 | 28809441 | Design and Fabrication of Temperature-Sensitive Nanogels with Controlled Drug Release Properties for Enhanced Photothermal Sterilization. | Chemistry | 2017 | https://conductscience.org/library/papers/28809441 | PubMed |
| 3 | 40111115 | Hyaluronic acid methacryloyl hydrogel with sustained IL-10 release promotes macrophage M2 polarization and motor function after spinal cord injury. | J Biomater Appl | 2025 | https://conductscience.org/library/papers/40111115 | PubMed |
| 4 | 35126134 | Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/35126134 | PubMed |
| 5 | 12640314 | Interindividual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with genetic polymorphisms. | Transplantation | 2003 | https://conductscience.org/library/papers/12640314 | PubMed |
| 6 | 39467606 | Acute respiratory distress syndrome. | BMJ | 2024 | https://conductscience.org/library/papers/39467606 | PubMed |
| 7 | 32528277 | Biological Considerations in Scaling Up Therapeutic Cell Manufacturing. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/32528277 | PubMed |
| 8 | 39090662 | CPT1A-IL-10-mediated macrophage metabolic and phenotypic alterations ameliorate acute lung injury. | Clin Transl Med | 2024 | https://conductscience.org/library/papers/39090662 | PubMed |
| 9 | 34983336 | Applications of Lipid-based Nanocarriers for Parenteral Drug Delivery. | Curr Med Chem | 2022 | https://conductscience.org/library/papers/34983336 | PubMed |
| 10 | 7512027 | Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. | Eur J Immunol | 1994 | https://conductscience.org/library/papers/7512027 | PubMed |
| 11 | 32397765 | DPPC-coated lipid nanoparticles as an inhalable carrier for accumulation of resveratrol in the pulmonary vasculature, a new strategy for pulmonary arterial hypertension treatment. | Drug Deliv | 2020 | https://conductscience.org/library/papers/32397765 | PubMed |
| 12 | 38348174 | PLGA-Chitosan Encapsulated IL-10 Nanoparticles Modulate Chlamydia Inflammation in Mice. | Int J Nanomedicine | 2024 | https://conductscience.org/library/papers/38348174 | PubMed |
| 13 | 36585961 | PEGylated IL-10: Clinical Development in Cancer Immunotherapy, Where to Go? | Curr Oncol Rep | 2023 | https://conductscience.org/library/papers/36585961 | PubMed |
| 14 | 33360827 | Intranasal delivery of MSC-derived exosomes attenuates allergic asthma via expanding IL-10 producing lung interstitial macrophages in mice. | Int Immunopharmacol | 2021 | https://conductscience.org/library/papers/33360827 | PubMed |
| 15 | 34703841 | Engineered mesenchymal stromal cell therapy during human lung ex vivo lung perfusion is compromised by acidic lung microenvironment. | Mol Ther Methods Clin Dev | 2021 | https://conductscience.org/library/papers/34703841 | PubMed |
| 16 | 11102780 | Tolerance to the foeto-placental 'graft': ten ways to support a child for nine months. | Curr Opin Immunol | 2000 | https://conductscience.org/library/papers/11102780 | PubMed |
| 17 | 40185557 | Severe Pneumonia. | Med Clin North Am | 2025 | https://conductscience.org/library/papers/40185557 | PubMed |
| 18 | 39636990 | Engineering synthetic suppressor T cells that execute locally targeted immunoprotective programs. | Science | 2024 | https://conductscience.org/library/papers/39636990 | PubMed |
| 19 | 33869188 | More Human BM-MSC With Similar Subpopulation Composition and Functional Characteristics Can Be Produced With a GMP-Compatible Fabric Filter System Compared to Density Gradient Technique. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/33869188 | PubMed |
| 20 | 2531194 | Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. | J Exp Med | 1989 | https://conductscience.org/library/papers/2531194 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42916439 | Respirable Particulate Matter Induces Natural Killer Cell Dysfunction via Oxidative Stress-Mediated Lysosomal and Mitochondrial Injury: Implications for Mineral-Rich Mining Dust Exposure. | Environ Sci Technol | 2026 | https://conductscience.org/library/papers/42916439 | PubMed |
| 42042831 | The Role of Lung Microbiota in Shaping Host Immunity and Mucosal Vaccine Responses. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42042831 | PubMed |
| 41668041 | Hypoxia-preconditioned mesenchymal stromal cell-derived exosomes attenuate LPS-induced acute lung injury and early epithelial remodeling in mice: evidence for a miR-486a-5p-Skp2-GATA4 axis. | Respir Res | 2026 | https://conductscience.org/library/papers/41668041 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IL10 | 3586 | PubTator's text mining | https://conductscience.org/library/genes/3586 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41312367
GET https://conductscience.org/api/papers/v1/41312367/references?page=2